ArticleNoro psikiyatri arsivi2025
The Use of Mismatch Negativity in Conjunction with Neuropsychological Tests to Discriminate Alzheimer's Dementia, Mild Cognitive Impairment and Healthy Aging.
Article in Noro psikiyatri arsivi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multimodal non-invasive approaches for early Alzheimer's disease detection: a review of neuroelectrophysiological and neuroimaging techniques.Frontiers in psychiatry · 2026Review
- Altered cognitive performance is associated with auditory cortex functional connectivity in patients with unilateral sensorineural hearing loss.Frontiers in neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Alzheimer's dementia (AD) is the most common type of dementia and it is important to detect AD by an appropriately cheap and non-invasive method in the mild cognitive impairment (MCI) phase, which is accepted as the prodromal phase of AD. We aimed to investigate whether AD patients, amnestic MCI (aMCI) patients, and healthy controls (HCs) could be distinguished from each other by using mismatch negativity (MMN) together with neuropsychological tests. Methods: Twenty-one individuals with mild AD, 26 with aMCI, and 18 HCs matched for age, sex, and education were included. Sociodemographic data, neuropsychological tests, Basic Activities of Daily Living (BADL) and Instrumental Activities of Daily Living (IADL) scores, and MMN parameters acquired using an auditory oddball paradigm with an interstimulus interval of 1 second were evaluated for all three groups. Results: There was no difference in terms of MMN latencies but frontal MMN amplitude was significantly lower in AD patients compared to the aMCI and HC groups. Linear regression analysis revealed that IADL scores were predicted by the Fz amplitude and Mini Mental State Examination and apathy scores. Logistic regression analysis showed that Fz amplitude, verbal fluency, and Neuropsychiatric Inventory total scores distinguished AD patients from HCs, while the Stroop 5 completion time distinguished those with MCI from HCs. Age, Fz amplitude, and verbal fluency performance distinguished AD patients from individuals with MCI. Conclusion: MMN might be a useful approach in differentiating AD from MCI and healthy aging when used together with neuropsychological tests rather than being used alone because it may be affected by confounding factors such as age, severity of temporoparietal neurodegeneration, and duration of the interstimulus interval.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.